Maximal cytoreductive surgery for advanced ovarian cancer (HTG668)Product type:GuidanceProgramme:HealthTech guidancePublished: 5 April 2023
Tests in secondary care to identify people at high risk of ovarian cancer (HTG453)Product type:GuidanceProgramme:HealthTech guidancePublished: 15 November 2017